Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 03:30:53 12/06/2026 pm IST			5-day change	1st Jan Change
2,120.70 ^INR	+0.86%		-2.11%	-14.17%

29/05	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
13/05	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,81,714	2,24,319	3,29,173	4,87,432	3,86,822	3,59,259	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	-7.13%	-
Enterprise Value (EV)	2,56,351	2,07,663	3,29,173	4,87,432	3,86,822	3,59,259	3,59,259
Change	-	-18.99%	58.51%	48.08%	-20.64%	-7.13%	0%
P/E Ratio	16.6x	36.7x	55.8x	52.5x	37.3x	31.5x	27.9x
PBR	10.6x	12.9x	18.5x	25x	17.1x	13.5x	11.5x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.1x	2.2x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	8.57x	7.73x
EV / Revenue	0x	0x	0x	0x	0x	8.57x	7.73x
EV / EBITDA	0x	0x	0x	0x	0x	24.5x	21.5x
EV / EBIT	0x	0x	0x	0x	0x	26.1x	22.8x
EV / FCF	0x	0x	0x	0x	0x	31x	28x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	3.23%	3.58%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.39%	1.39%
EPS ²	100	36.05	34.83	54.76	61.15	67.3	75.97
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.8%	38.8%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,939	46,453
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,683	16,675
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,402	12,873
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,120.70	2,120.70
Nbr of stocks (in thousands)	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	-
Announcement Date	16/05/22	17/05/23	17/05/24	13/05/25	13/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	31.24x	-	-	1.4%	372.02Cr
ELI LILLY AND COMPANY	33.97x	12.34x	25.42x	0.59%	1,03500Cr
JOHNSON & JOHNSON	25.47x	5.87x	15.96x	2.24%	57TCr
ABBVIE INC.	27.52x	6.71x	13.7x	3.05%	40TCr
ROCHE HOLDING AG	17.45x	4.31x	10.59x	3.08%	32TCr
ASTRAZENECA PLC	22.84x	4.75x	13.5x	1.84%	28TCr
NOVARTIS AG	21.11x	5.44x	13.22x	2.98%	28TCr
NOVO NORDISK A/S	12.49x	4.69x	9.58x	4.02%	19TCr
AMGEN INC.	23.02x	6.15x	10.74x	2.85%	19TCr
GILEAD SCIENCES, INC.	-45.04x	5.44x	30.73x	2.58%	16TCr
Average	17.01x	6.19x	15.94x	2.46%	34.34TCr
Weighted average by Cap.	22.88x	7.58x	17.64x	2.09%